Cvs beats on earnings and revenue as the company slashes costs

In this article * CVS Follow your favorite stocksCREATE FREE ACCOUNT A customer exits a CVS Health Corp. store in Oakland, California, U.S., on Friday, Aug. 2, 2019. Michael Short |

Bloomberg | Getty Images CVS Health on Wednesday reported second-quarter earnings and revenue that beat expectations, as the company slashes costs and lays off thousands of employees. CVS

has implemented a cost-cutting program as it pushes deeper into health-care services in the wake of its $8 billion acquisition of Signify Health and its $10.6 billion purchase of Oak Street

Health. Part of that effort calls for cutting 5,000 jobs, CNBC reported Tuesday. Here's what CVS recorded for its second quarter compared with Wall Street's expectations, based on

a survey of analysts by Refinitiv: * EARNINGS PER SHARE: $2.21 adjusted, vs. $2.11 expected * REVENUE: $88.9 billion, vs. $86.5 billion expected The health-care giant posted net income of

$1.91 billion for the quarter, or $1.48 per share, a 37% decline from the same period in 2022 when CVS reported net income of $3.04 billion, or $2.29 per share. Excluding one-time items, CVS

reported $2.21 per share for the period. The company booked revenue of $88.9 billion for the quarter, a 10% increase compared with the year-ago period. CVS maintained its full-year adjusted

earnings guidance of $8.50 to $8.70 per share, after slashing its projections by 20 cents last quarter due to costs associated with its recent acquisitions. MORE CNBC HEALTH COVERAGE * From

‘Cockroach Award’ to the Big Board: Hinge Health’s unlikely path to IPO * How UnitedHealthcare became the face of America’s health insurance frustrations * When 20,000 devices were

paralyzed by a bad update, a Georgia health system turned to Apple The company's health services segment generated $46.22 billion in revenue, a 7.6% increase compared with the same

quarter in 2022. The division includes the pharmacy benefit manager CVS Caremark and health-care services delivered in medical clinics, via telehealth and at home. CVS' retail pharmacy

division generated $28.78 billion in sales, also 7.6% higher than the year ago-period, driven by increased prescription volume. The number of prescriptions filled rose 2.4% on a 30-day

basis, excluding Covid-19 vaccinations. Same-store prescription volume jumped nearly 5%, excluding Covid vaccines. The company's health insurance segment generated $26.75 billion, a

17.6% increase over the second quarter of 2022. That division includes Aetna plans for the Affordable Care Act, Medicare Advantage, Medicaid, and dental and vision. The insurance

segment's medical benefit ratio — a measure of total medical expenses paid relative to premiums collected — rose to 86.2% in the quarter, compared with 82.7% in the year-ago period. A

lower ratio typically indicates that the company collected more in premiums than it paid out in benefits, resulting in higher profitability.